XBiotech Inc.
Develops therapeutic antibodies from natural human immunity for inflammatory diseases and oncology.
XBIT | US
Overview
Corporate Details
- ISIN(s):
- CA98400H1029
- LEI:
- Country:
- United States of America
- Address:
- 5217 WINNEBAGO LANE, 78744 AUSTIN
- Website:
- https://www.xbiotech.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
XBiotech Inc. is a fully integrated, clinical-stage biosciences company specializing in the discovery, development, and commercialization of therapeutic antibodies. The company's core innovation is its proprietary True Human™ platform, which develops monoclonal antibodies derived directly from the natural immunity of human donors. This approach aims to create therapies that are potentially safer and more effective than engineered antibodies. XBiotech's pipeline targets a range of unmet medical needs, with a focus on diseases involving inflammation. Key therapeutic areas include oncology, neurology, rheumatology, and anti-infectives. The company maintains control over the entire process, from antibody discovery and clinical research to its in-house manufacturing capabilities.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all XBiotech Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for XBiotech Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for XBiotech Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
